{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T20:27:19Z","timestamp":1790368039190,"version":"4.1.0"},"reference-count":243,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    Chronic liver diseases represent a major global health burden, with fibrosis as the common pathological outcome of sustained hepatic injury. Once considered irreversible, liver fibrosis is now recognized as a dynamic and potentially reversible process driven by complex cellular and molecular interactions within the hepatic microenvironment. Among these, hepatic macrophages have emerged as central regulators of both fibrogenesis and fibrosis resolution due to their remarkable phenotypic and functional plasticity. This review integrate experimental, translational, and emerging clinical evidence to propose macrophage reprogramming as a unifying therapeutic framework for liver fibrosis. A broad spectrum of intervention strategies -including gene modulation, pharmacological agents, immunometabolic reprogramming, nanotechnology-based delivery systems, and cell-based therapies- converges on promoting restorative macrophage phenotypes across toxic, metabolic, cholestatic, and inflammatory liver diseases. Particular emphasis is placed on key signaling and metabolic circuits -such as NF-\u03baB, STAT1\/3\/6, PPAR\u03b1\/\u03b3, AMPK, mitochondrial function, and autophagy- that collectively govern macrophage fate and function. The context-dependent nature of macrophage responses is highlighted, underscoring critical differences between toxic injury models (e.g., CCl\n                    <jats:sub>4<\/jats:sub>\n                    ) and chronic metabolic conditions such as MASH, where macrophage heterogeneity and immunometabolic dysregulation impose additional therapeutic challenges. Emerging clinical data indicate that many antifibrotic strategies -despite distinct primary targets- converge on shared pathways of macrophage modulation, reinforcing their role as integrative hubs linking inflammation, metabolism, and tissue repair. Collectively, current findings indicate that durable fibrosis regression is unlikely to be achieved through single-target interventions. Instead, effective therapeutic strategies will require coordinated, temporally defined modulation of macrophages alongside other hepatic cells populations. Elucidation of the hierarchy and timing of macrophage-driven repair processes will be essential for the rational design of next-generation antifibrotic interventions with improved clinical efficacy.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2026.1792423","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T04:29:27Z","timestamp":1778560167000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Strategies to promote liver fibrosis amelioration with involvement of restorative macrophages"],"prefix":"10.3389","volume":"17","author":[{"given":"Jorge Benjamin","family":"Aquino","sequence":"first","affiliation":[{"name":"Developmental Biology & Regenerative Medicine Laboratory, Instituto de Investigaciones en Medicina Traslacional, CONICET-Universidad Austral, Derqui","place":["Pilar, Buenos Aires, Argentina"]},{"name":"Facultad de Ciencias Biom\u00e9dicas, Universidad Austral","place":["Derqui, Pilar, Buenos Aires, Argentina"]},{"name":"Facultad de Ingenier\u00eda, Universidad Austral","place":["Derqui, Pilar, Buenos Aires, Argentina"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1119964109","article-title":"Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis","volume":"109","author":"Ramachandran","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"B2","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1186\/s13287-024-03896-w","article-title":"The antifibrotic potential of IMT504: modulation of GLAST + Wnt1 + bone marrow stromal progenitors and hepatic microenvironment","volume":"15","author":"Borda","year":"2024","journal-title":"Stem Cell Res Ther"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1002\/sctm.18-0105","article-title":"Mesenchymal stem cells and induced bone marrow-derived macrophages synergistically improve liver fibrosis in mice","volume":"8","author":"Watanabe","year":"2019","journal-title":"Stem Cells Transl Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abq6225","article-title":"RNF41 orchestrates macrophage-driven fibrosis resolution and hepatic regeneration","volume":"15","author":"Moreno-Lanceta","year":"2023","journal-title":"Sci Transl Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/srep18272","article-title":"The interplay of the Notch signaling in hepatic stellate cells and macrophages determines the fate of liver fibrogenesis","volume":"5","author":"Bansal","year":"2015","journal-title":"Sci Rep"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/liv.70341","article-title":"Reactive oxygen species-mediated TRPM2 activation facilitates phagocytosis of macrophages to reverse profibrotic phenotype","volume":"45","author":"Zhang","year":"2025","journal-title":"Liver Int"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adv2106","article-title":"Impaired TIM4-mediated efferocytosis by liver macrophages contributes to fibrosis in metabolic dysfunction-associated steatohepatitis","volume":"17","author":"Shi","year":"2025","journal-title":"Sci Transl Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2020.08.004","article-title":"Osteopontin expression identifies a subset of recruited macrophages distinct from Kupffer cells in the fatty liver","volume":"53","author":"Remmerie","year":"2020","journal-title":"Immunity"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.108626","article-title":"Dynamic shifts in the composition of resident and recruited macrophages influence tissue remodeling in NASH","volume":"34","author":"Daemen","year":"2021","journal-title":"Cell Rep"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2405746121","article-title":"Lipid-associated macrophages' promotion of fibrosis resolution during MASH regression requires TREM2","volume":"121","author":"Ganguly","year":"2024","journal-title":"Proc Natl Acad Sci USA"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2025.05.013","article-title":"Spatially restricted and ontogenically distinct hepatic macrophages are required for tissue repair","volume":"58","author":"De Ponti","year":"2025","journal-title":"Immunity"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2003.24","article-title":"Induction of nitric oxide synthase (NOS) by soluble glucocorticoid induced tumor necrosis factor receptor (sGITR) is modulated by IFN-gamma in murine macrophage","volume":"35","author":"Shin","year":"2003","journal-title":"Exp Mol Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"24638","DOI":"10.1038\/s41598-025-09002-1","article-title":"A network pharmacology approach confirms Biejiaxiaozheng pills combat hepatic fibrosis by modulating macrophage inflammation and hepatic stellate cell activation","volume":"15","author":"Wu","year":"2025","journal-title":"Sci Rep"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2024.107984","article-title":"The methyltransferase MLL4 promotes nonalcoholic steatohepatitis by enhancing NF-kappaB signaling","volume":"300","author":"Lee","year":"2024","journal-title":"J Biol Chem"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1142\/s0192415x2350057x","article-title":"Paeoniflorin coordinates macrophage polarization and mitigates liver inflammation and fibrogenesis by targeting the NF-[Formula: see text]B\/HIF-1alpha pathway in CCl(4)-induced liver fibrosis","volume":"51","author":"Liu","year":"2023","journal-title":"Am J Chin Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27394","article-title":"Myeloid-specific disruption of recombination signal binding protein Jkappa ameliorates hepatic fibrosis by attenuating inflammation through cylindromatosis in mice","volume":"61","author":"He","year":"2015","journal-title":"Hepatology"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.2337\/db16-1446","article-title":"Myeloid Sirtuin 6 deficiency causes insulin resistance in high-fat diet-fed mice by eliciting macrophage polarization toward an M1 phenotype","volume":"66","author":"Lee","year":"2017","journal-title":"Diabetes"},{"key":"B18","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/path.5548","article-title":"Differential TM4SF5-mediated SIRT1 modulation and metabolic signaling in nonalcoholic steatohepatitis progression","volume":"253","author":"Ryu","year":"2021","journal-title":"J Pathol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.110018","article-title":"TM4SF5-dependent crosstalk between hepatocytes and macrophages to reprogram the inflammatory environment","volume":"37","author":"Kim","year":"2021","journal-title":"Cell Rep"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0901698","article-title":"Substrate fate in activated macrophages: a comparison between innate, classic, and alternative activation","volume":"185","author":"Rodr\u00edguez-Prados","year":"2010","journal-title":"J Immunol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.cmet.2006.05.011","article-title":"Oxidative metabolism and PGC-1beta attenuate macrophage-mediated inflammation","volume":"4","author":"Vats","year":"2006","journal-title":"Cell Metab"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2020.101634","article-title":"Annexin A5 regulates hepatic macrophage polarization via directly targeting PKM2 and ameliorates NASH","volume":"36","author":"Xu","year":"2020","journal-title":"Redox Biol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.73890","article-title":"Covalent inhibition of pyruvate kinase M2 reprograms metabolic and inflammatory pathways in hepatic macrophages against non-alcoholic fatty liver disease","volume":"18","author":"Fan","year":"2022","journal-title":"Int J Biol Sci"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1097\/tp.0000000000005461","article-title":"PKM2 drives lactate-mediated fibrosis in liver transplantation","volume":"109","author":"Liu","year":"2025","journal-title":"Transplantation"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2021-325150","article-title":"FSTL1 promotes liver fibrosis by reprogramming macrophage function through modulating the intracellular function of PKM2","volume":"71","author":"Rao","year":"2022","journal-title":"Gut"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1544973","article-title":"Chitinase-1 inhibition attenuates metabolic dysregulation and restores homeostasis in MASH animal models","volume":"16","author":"Drzewicka","year":"2025","journal-title":"Front Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202400413","article-title":"Mitochondria-regulated information processing nanosystem promoting immune cell communication for liver fibrosis regression","volume":"20","author":"Che","year":"2024","journal-title":"Small"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.reth.2025.01.017","article-title":"Human placental extract improves liver cirrhosis in mice with regulation of macrophages and senescent cells","volume":"28","author":"Ishikawa","year":"2025","journal-title":"Regener Ther"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/978-981-15-7360-6_21","article-title":"Prevention of NAFLD\/NASH by astaxanthin and beta-cryptoxanthin","volume":"1261","author":"Ota","year":"2021","journal-title":"Adv Exp Med Biol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00352.2017","article-title":"PPARalpha agonist fenofibrate enhances fatty acid beta-oxidation and attenuates polycystic kidney and liver disease in mice","volume":"314","author":"Lakhia","year":"2018","journal-title":"Am J Physiol Renal Physiol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1007\/s10753-025-02308-2","article-title":"Alpha ketoglutaric acid attenuates LPS induced inflammatory response by inhibiting the PKCepsilon\/MAPK\/P65 signaling pathway and inhibit oxidative stress in Kupffer cells","volume":"48","author":"Li","year":"2025","journal-title":"Inflammation"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/s41401-024-01389-3","article-title":"SGLT2 inhibitors ameliorate NAFLD in mice via downregulating PFKFB3, suppressing glycolysis and modulating macrophage polarization","volume":"45","author":"Lin","year":"2024","journal-title":"Acta Pharmacol Sin"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1097\/hep.0000000000001427","article-title":"Dissecting the liver inflammation ecosystem identifies annexin A1 as a pro-resolving target for liver failure","volume":"83","author":"Yu","year":"2025","journal-title":"Hepatology"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/8790369","article-title":"Target Sestrin2 to rescue the damaged organ: mechanistic insight into its function","volume":"2021","author":"Ala","year":"2021","journal-title":"Oxid Med Cell Longev"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103314","article-title":"Carbon monoxide-loaded red blood cells ameliorate metabolic dysfunction-associated steatohepatitis progression via enhancing AMP-activated protein kinase activity and inhibiting Kupffer cell activation","volume":"76","author":"Yanagisawa","year":"2024","journal-title":"Redox Biol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.cub.2004.02.048","article-title":"AMPK signaling in health and disease","volume":"45","author":"Carling","year":"2017","journal-title":"Curr Opin Cell Biol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.114053","article-title":"The natural product-derived JM-9 alleviates high-fat diet-induced fatty liver in mice by targeting MD2","volume":"148","author":"Jin","year":"2025","journal-title":"Int Immunopharmacol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/978-981-15-0602-4_4","article-title":"AMPK and autophagy","volume":"1206","author":"Li","year":"2019","journal-title":"Adv Exp Med Biol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1374644","article-title":"The pivotal role of dysregulated autophagy in the progression of non-alcoholic fatty liver disease","volume":"15","author":"Shen","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1002\/tox.23795","article-title":"Autophagy affects hepatic fibrosis progression by regulating macrophage polarization and exosome secretion","volume":"38","author":"Hu","year":"2023","journal-title":"Environ Toxicol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2021.173976","article-title":"Research progress in use of traditional Chinese medicine monomer for treatment of non-alcoholic fatty liver disease","volume":"898","author":"Zhou","year":"2021","journal-title":"Eur J Pharmacol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10020319","article-title":"Metformin inhibits ROS production by human M2 macrophages via the activation of AMPK","volume":"10","author":"Nassif","year":"2022","journal-title":"Biomedicines"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.2337\/db19-0991","article-title":"Empagliflozin ameliorates obesity-related cardiac dysfunction by regulating Sestrin2-mediated AMPK-mTOR signaling and redox homeostasis in high-fat diet-induced obese mice","volume":"69","author":"Sun","year":"2020","journal-title":"Diabetes"},{"key":"B44","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.bbrc.2020.03.032","article-title":"Liraglutide ameliorates obesity-related nonalcoholic fatty liver disease by regulating Sestrin2-mediated Nrf2\/HO-1 pathway","volume":"525","author":"Han","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2025.120029","article-title":"Biejia ruangan tablet alleviated liver fibrosis in murine models by hindering the crosstalk between hepatic stellate cells and M2-like macrophages through PDGF-AA\/PI3K\/AKT pathway","volume":"350","author":"Chen","year":"2025","journal-title":"J Ethnopharmacol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.117730","article-title":"Integration of network pharmacology and serum medicinal chemistry to investigate the pharmacological mechanisms of QiZhuYangGan decoction in the treatment of hepatic fibrosis","volume":"323","author":"Deng","year":"2024","journal-title":"J Ethnopharmacol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118677","article-title":"Interleukin-22 regulating Kupffer cell polarization through STAT3\/Erk\/Akt crosstalk pathways to extenuate liver fibrosis","volume":"264","author":"Su","year":"2021","journal-title":"Life Sci"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114264","article-title":"Phillygenin inhibited M1 macrophage polarization and reduced hepatic stellate cell activation by inhibiting macrophage exosomal miR-125b-5p","volume":"159","author":"Ma","year":"2023","journal-title":"BioMed Pharmacother"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-018-0383-0","article-title":"PSTPIP2 connects DNA methylation to macrophage polarization in CCL4-induced mouse model of hepatic fibrosis","volume":"37","author":"Yang","year":"2018","journal-title":"Oncogene"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2023.117486","article-title":"Jiawei Taohe Chengqi decoction inhibition of the notch signal pathway affects macrophage reprogramming to inhibit HSCs activation for the treatment of hepatic fibrosis","volume":"321","author":"Shao","year":"2024","journal-title":"J Ethnopharmacol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.104983","article-title":"Heme oxygenase-1 mitigates liver injury and fibrosis via modulation of LNX1\/Notch1 pathway in myeloid cells","volume":"25","author":"Canesin","year":"2022","journal-title":"IScience"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.00071","article-title":"Myricetin modulates macrophage polarization and mitigates liver inflammation and fibrosis in a murine model of nonalcoholic steatohepatitis","volume":"7","author":"Yao","year":"2020","journal-title":"Front Med (Lausanne)"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v22.i42.9368","article-title":"IRF5 regulates lung macrophages M2 polarization during severe acute pancreatitis in vitro","volume":"22","author":"Sun","year":"2016","journal-title":"World J Gastroenterol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"631","DOI":"10.21037\/atm-21-4809","article-title":"Yinzhihuang oral liquid protects against non-alcoholic steatohepatitis via modulation of the gut-liver axis in mice","volume":"10","author":"Li","year":"2022","journal-title":"Ann Transl Med"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1080\/21655979.2022.2066756","article-title":"Selective bromodomain and extra-terminal bromodomain inhibitor inactivates macrophages and hepatic stellate cells to inhibit liver inflammation and fibrosis","volume":"13","author":"Fu","year":"2022","journal-title":"Bioengineered"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1417521","article-title":"Activation of MEK-ERK-c-MYC signaling pathway promotes splenic M2-like macrophage polarization to inhibit PHcH-liver cirrhosis","volume":"15","author":"Guihu","year":"2024","journal-title":"Front Immunol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.111045","article-title":"MMP10 alleviates non-alcoholic steatohepatitis by regulating macrophage M2 polarization","volume":"124","author":"Chang","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v16.i11.1306","article-title":"Development and validation of biomarkers related to anoikis in liver cirrhosis based on bioinformatics analysis","volume":"16","author":"Luo","year":"2024","journal-title":"World J Hepatol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1528382","article-title":"Type I IFN receptor blockade alleviates liver fibrosis through macrophage-derived STAT3 signaling","volume":"16","author":"Park","year":"2025","journal-title":"Front Immunol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1701247","article-title":"The STAT3-IL-10-IL-6 pathway is a novel regulator of macrophage efferocytosis and phenotypic conversion in sterile liver injury","volume":"200","author":"Campana","year":"2018","journal-title":"J Immunol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3390\/cells12040663","article-title":"Sirtuin 6-a key regulator of hepatic lipid metabolism and liver health","volume":"12","author":"Dong","year":"2023","journal-title":"Cells"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.2174\/0115748928318948240920044716","article-title":"Quercetin promotes the M1-to-M2 macrophage phenotypic switch during liver fibrosis treatment by modulating the JAK2\/STAT3 signaling pathway","volume":"21","author":"Sun","year":"2024","journal-title":"Recent Pat Anticancer Drug Discov"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1111\/1348-0421.12937","article-title":"The role of C\/EBP homologous protein (CHOP) in regulating macrophage polarization in RAW264.7 cells","volume":"65","author":"Liu","year":"2021","journal-title":"Microbiol Immunol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1002\/cbin.11916","article-title":"The effect of mesenchymal stem cells and imatinib on macrophage polarization in rat model of liver fibrosis","volume":"47","author":"Malmir","year":"2023","journal-title":"Cell Biol Int"},{"key":"B65","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.ebiom.2018.01.028","article-title":"IL-4 receptor alpha signaling through macrophages differentially regulates liver fibrosis progression and reversal","volume":"29","author":"Weng","year":"2018","journal-title":"EBioMedicine"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1172\/jci154333","article-title":"Myeloid FoxO1 depletion attenuates hepatic inflammation and prevents nonalcoholic steatohepatitis","volume":"132","author":"Lee","year":"2022","journal-title":"J Clin Invest"},{"key":"B67","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.freeradbiomed.2023.03.014","article-title":"Irisin drives macrophage anti-inflammatory differentiation via JAK2-STAT6-dependent activation of PPARgamma and Nrf2 signaling","volume":"201","author":"Tu","year":"2023","journal-title":"Free Radic Biol Med"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.3390\/antiox12091718","article-title":"Sappanone A alleviates the severity of carbon tetrachloride-induced liver fibrosis in mice","volume":"12","author":"Qi","year":"2023","journal-title":"Antioxidants (Basel)"},{"key":"B69","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/s13287-023-03416-2","article-title":"PPARgamma-dependent hepatic macrophage switching acts as a central hub for hUCMSC-mediated alleviation of decompensated liver cirrhosis in rats","volume":"14","author":"Yao","year":"2023","journal-title":"Stem Cell Res Ther"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15051452","article-title":"PPAR-gamma agonist GW1929 targeted to macrophages with dendrimer-graphene nanostars reduces liver fibrosis and inflammation","volume":"15","author":"Moreno-Lanceta","year":"2023","journal-title":"Pharmaceutics"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.13853","article-title":"Honokiol attenuates diet-induced non-alcoholic steatohepatitis by regulating macrophage polarization through activating peroxisome proliferator-activated receptor gamma","volume":"33","author":"Zhong","year":"2018","journal-title":"J Gastroenterol Hepatol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.m117.778761","article-title":"Protein arginine methyltransferase 1 modulates innate immune responses through regulation of peroxisome proliferator-activated receptor gamma-dependent macrophage differentiation","volume":"292","author":"Tikhanovich","year":"2017","journal-title":"J Biol Chem"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1528768","article-title":"1,25-dihydroxyvitamin D3 improves non-alcoholic steatohepatitis phenotype in a diet-induced rat model","volume":"16","author":"Liu","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2007.06.010","article-title":"PPARgamma activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties","volume":"6","author":"Bouhlel","year":"2007","journal-title":"Cell Metab"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2022.166590","article-title":"Myeloid- and hepatocyte-specific deletion of group VIA calcium-independent phospholipase A2 leads to dichotomous opposing phenotypes during MCD diet-induced NASH","volume":"1869","author":"Jansakun","year":"2023","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.2147\/jir.s480574","article-title":"Regulation of inflammation, lipid metabolism, and liver fibrosis by core genes of M1 macrophages in NASH","volume":"17","author":"Xu","year":"2024","journal-title":"J Inflammation Res"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.98362","article-title":"Multiomics analyses decipher intricate changes in the cellular and metabolic landscape of steatotic livers upon dietary restriction and sleeve gastrectomy","volume":"20","author":"Chen","year":"2024","journal-title":"Int J Biol Sci"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1002\/hep4.1178","article-title":"Neutrophils alleviate fibrosis in the CCl(4)-induced mouse chronic liver injury model","volume":"2","author":"Saijou","year":"2018","journal-title":"Hepatol Commun"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmgh.2025.101525","article-title":"Continuous activation of C\/EBPbeta transcription factor prevents fibrosis resolution after alcohol cessation","volume":"19","author":"Schonfeld","year":"2025","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.687744","article-title":"Nobiletin alleviates non-alcoholic steatohepatitis in MCD-induced mice by regulating macrophage polarization","volume":"12","author":"Wang","year":"2021","journal-title":"Front Physiol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2025.110341","article-title":"Lactucin alleviates liver fibrosis by regulating the TLR4-MyD88-MAPK\/NF-kappaB signaling pathway through intestinal flora","volume":"766","author":"Zhu","year":"2025","journal-title":"Arch Biochem Biophys"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.23816","article-title":"KLF4-induced upregulation of SOCS1 ameliorates myocardial ischemia\/reperfusion injury by attenuating AC16 cardiomyocyte damage and enhancing M2 macrophage polarization","volume":"38","author":"Zhou","year":"2024","journal-title":"J Biochem Mol Toxicol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"5341","DOI":"10.1038\/s41467-020-18925-4","article-title":"Early-onset autoimmunity associated with SOCS1 haploinsufficiency","volume":"11","author":"Hadjadj","year":"2020","journal-title":"Nat Commun"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1007\/s12011-023-03648-6","article-title":"NaAsO(2) regulates TLR4\/MyD88\/NF-kappaB signaling pathway through DNMT1\/SOCS1 to cause apoptosis and inflammation in hepatic BRL-3A cells","volume":"202","author":"Li","year":"2024","journal-title":"Biol Trace Elem Res"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmgh.2024.101406","article-title":"Sphingosine kinase 1 aggravates liver fibrosis by mediating macrophage recruitment and polarization","volume":"18","author":"Ding","year":"2024","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.114662","article-title":"E3 ubiquitin ligase TRIM38 regulates macrophage polarization to reduce hepatic inflammation by interacting with HSPA5","volume":"157","author":"Yang","year":"2025","journal-title":"Int Immunopharmacol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1202909","article-title":"Chemokine receptor CXCR6-dependent hepatic NK T cell accumulation promotes inflammation and liver fibrosis","volume":"190","author":"Wehr","year":"2013","journal-title":"J Immunol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmgh.2022.12.005","article-title":"Fibroblast activation protein activates macrophages and promotes parenchymal liver inflammation and fibrosis","volume":"15","author":"Yang","year":"2023","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28418","article-title":"Histidine-rich glycoprotein promotes macrophage activation and inflammation in chronic liver disease","volume":"63","author":"Bartneck","year":"2016","journal-title":"Hepatology"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01214","article-title":"Cannabinoid receptor 1 participates in liver inflammation by promoting M1 macrophage polarization via RhoA\/NF-kappaB p65 and ERK1\/2 pathways, respectively, in mouse liver fibrogenesis","volume":"8","author":"Tian","year":"2017","journal-title":"Front Immunol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1021\/acsami.2c22579","article-title":"Liver-targeted delivery of small interfering RNA of C-C chemokine receptor 2 with tetrahedral framework nucleic acid attenuates liver cirrhosis","volume":"15","author":"Tian","year":"2023","journal-title":"ACS Appl Mater Interfaces"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.83530","article-title":"C-C motif chemokine receptor 2 inhibition reduces liver fibrosis by restoring the immune cell landscape","volume":"19","author":"Guo","year":"2023","journal-title":"Int J Biol Sci"},{"key":"B93","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1002\/hep.24764","article-title":"Hepatic macrophage migration and differentiation critical for liver fibrosis is mediated by the chemokine receptor C-C motif chemokine receptor 8 in mice","volume":"55","author":"Heymann","year":"2012","journal-title":"Hepatology"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1096\/fj.04-2753fje","article-title":"The selective cyclooxygenase-2 inhibitor SC-236 reduces liver fibrosis by mechanisms involving non-parenchymal cell apoptosis and PPARgamma activation","volume":"19","author":"Planagum\u00e0","year":"2005","journal-title":"FASEB J"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1172\/jci98156","article-title":"The innate immune receptor TREM-1 promotes liver injury and fibrosis","volume":"128","author":"Nguyen-Lefebvre","year":"2018","journal-title":"J Clin Invest"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2019.4395","article-title":"Margatoxin mitigates CCl4-induced hepatic fibrosis in mice via macrophage polarization, cytokine secretion and STAT signaling","volume":"45","author":"Wu","year":"2020","journal-title":"Int J Mol Med"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1021\/acs.nanolett.8b02498","article-title":"Graphene-dendrimer nanostars for targeted macrophage overexpression of metalloproteinase 9 and hepatic fibrosis precision therapy","volume":"18","author":"Melgar-Lesmes","year":"2018","journal-title":"Nano Lett"},{"key":"B98","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.trsl.2020.04.011","article-title":"Cathepsin B deficiency ameliorates liver lipid deposition, inflammatory cell infiltration, and fibrosis after diet-induced nonalcoholic steatohepatitis","volume":"222","author":"Fang","year":"2020","journal-title":"Transl Res"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1210\/endocr\/bqaa139","article-title":"DPP-4 inhibition with anagliptin reduces lipotoxicity-induced insulin resistance and steatohepatitis in male mice","volume":"161","author":"Sakai","year":"2020","journal-title":"Endocrinology"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00553.2014","article-title":"DPP-IV inhibitor anagliptin exerts anti-inflammatory effects on macrophages, adipocytes, and mouse livers by suppressing NF-kappaB activation","volume":"309","author":"Shinjo","year":"2015","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B101","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.jhep.2016.10.023","article-title":"Parp inhibition protects against alcoholic and non-alcoholic steatohepatitis","volume":"66","author":"Mukhopadhyay","year":"2017","journal-title":"J Hepatol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26783","article-title":"Pharmacological inhibition of the chemokine C-C motif chemokine ligand 2 (monocyte chemoattractant protein 1) accelerates liver fibrosis regression by suppressing Ly-6C(+) macrophage infiltration in mice","volume":"59","author":"Baeck","year":"2014","journal-title":"Hepatology"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2021.154914","article-title":"Cc chemokine ligand 3 deficiency ameliorates diet-induced steatohepatitis by regulating liver macrophage recruitment and M1\/M2 status in mice","volume":"125","author":"Xu","year":"2021","journal-title":"Metabolism"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.3390\/antiox13111336","article-title":"Inhibiting ferroptosis prevents the progression of steatotic liver disease in obese mice","volume":"13","author":"Park","year":"2024","journal-title":"Antioxidants (Basel)"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.96113","article-title":"Sirna-loaded folic acid-modified TPGS alleviate MASH via targeting ER stress sensor XBP1 and reprogramming macrophages","volume":"20","author":"Zhu","year":"2024","journal-title":"Int J Biol Sci"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2022.02.031","article-title":"Role of XBP1 in regulating the progression of non-alcoholic steatohepatitis","volume":"77","author":"Wang","year":"2022","journal-title":"J Hepatol"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1093\/glycob\/cwad062","article-title":"Galectin-12 modulates Kupffer cell polarization to alter the progression of nonalcoholic fatty liver disease","volume":"33","author":"Lee","year":"2023","journal-title":"Glycobiology"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2022.01.038","article-title":"Hepatic macrophage targeted sirna lipid nanoparticles treat non-alcoholic steatohepatitis","volume":"343","author":"Zhou","year":"2022","journal-title":"J Control Release"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.09.010","article-title":"Expression of STING is increased in liver tissues from patients with NAFLD and promotes macrophage-mediated hepatic inflammation and fibrosis in mice","volume":"155","author":"Luo","year":"2018","journal-title":"Gastroenterology"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-025-01408-1","article-title":"A1AT dysregulation of metabolically stressed hepatocytes by Kupffer cells drives MASH and fibrosis","volume":"57","author":"Park","year":"2025","journal-title":"Exp Mol Med"},{"key":"B111","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41392-024-01797-1","article-title":"Mettl14 downregulation drives S100A4(+) monocyte-derived macrophages via MyD88\/NF-kappaB pathway to promote MAFLD progression","volume":"9","author":"Wang","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00310.2019","article-title":"Immune modulating effects of additional supplementation of estradiol combined with testosterone in murine testosterone-deficient NAFLD model","volume":"318","author":"Okamura","year":"2020","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23894","article-title":"The fractalkine receptor CX(3)CR1 protects against liver fibrosis by controlling differentiation and survival of infiltrating hepatic monocytes","volume":"52","author":"Karlmark","year":"2010","journal-title":"Hepatology"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2022.155272","article-title":"Cx3cl1\/cx3cr1 interaction protects against lipotoxicity-induced nonalcoholic steatohepatitis by regulating macrophage migration and M1\/M2 status","volume":"136","author":"Ni","year":"2022","journal-title":"Metabolism"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1042\/cs20110515","article-title":"Lack of CC chemokine ligand 2 differentially affects inflammation and fibrosis according to the genetic background in a murine model of steatohepatitis","volume":"123","author":"Galastri","year":"2012","journal-title":"Clin Sci (Lond)"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202308750","article-title":"Protozoan-derived cytokine-transgenic macrophages reverse hepatic fibrosis","volume":"11","author":"Chen","year":"2024","journal-title":"Adv Sci (Weinh)"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/8591892","article-title":"Fuzheng Huayu recipe prevented and treated CCl4-induced mice liver fibrosis through regulating polarization and chemotaxis of intrahepatic macrophages via CCL2 and CX3CL1","volume":"2020","author":"Zhang","year":"2020","journal-title":"Evid Based Complement Alternat Med"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.9259","article-title":"Il-33 treatment attenuated diet-induced hepatic steatosis but aggravated hepatic fibrosis","volume":"7","author":"Gao","year":"2016","journal-title":"Oncotarget"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1080\/08820139.2025.2565735","article-title":"Effects of sapropterin against non-alcoholic fatty liver disease in mice","volume":"54","author":"Jiang","year":"2025","journal-title":"Immunol Invest"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.107438","article-title":"Hyperoside attenuates non-alcoholic fatty liver disease through targeting Nr4A1 in macrophages","volume":"94","author":"Sun","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0291880","article-title":"Macrophage specific restoration of the Nrf2 gene in whole-body knockout mice ameliorates steatohepatitis induced by lipopolysaccharide from Porphyromonas gingivalis through enhanced hepatic clearance","volume":"18","author":"Chihara","year":"2023","journal-title":"PloS One"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2019.06.045","article-title":"Expression of Vsig4 attenuates macrophage-mediated hepatic inflammation and fibrosis in high fat diet (HFD)-induced mice","volume":"516","author":"Li","year":"2019","journal-title":"Biochem Biophys Res Commun"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.01.035","article-title":"The pro-inflammatory effects of miR-155 promote liver fibrosis and alcohol-induced steatohepatitis","volume":"64","author":"Bala","year":"2016","journal-title":"J Hepatol"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.08.011","article-title":"Therapeutic HNF4A mRNA attenuates liver fibrosis in a preclinical model","volume":"75","author":"Yang","year":"2021","journal-title":"J Hepatol"},{"key":"B125","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s13287-016-0424-y","article-title":"Involvement of hepatic macrophages in the antifibrotic effect of IGF-I-overexpressing mesenchymal stromal cells","volume":"7","author":"Fiore","year":"2016","journal-title":"Stem Cell Res Ther"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2020.8826","article-title":"Mechanism of TGF-beta1 inhibiting Kupffer cell immune responses in cholestatic cirrhosis","volume":"20","author":"Qian","year":"2020","journal-title":"Exp Ther Med"},{"key":"B127","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1038\/s41467-018-03299-5","article-title":"Paracrine cellular senescence exacerbates biliary injury and impairs regeneration","volume":"9","author":"Ferreira-Gonzalez","year":"2018","journal-title":"Nat Commun"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0079270","article-title":"The heme oxygenase system rescues hepatic deterioration in the condition of obesity co-morbid with type-2 diabetes","volume":"8","author":"Salley","year":"2013","journal-title":"PloS One"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmii.2025.07.001","article-title":"Interleukin 27 (IL-27) productions in the liver microenvironment confer an immunosuppressive role and enhance hepatitis B viral persistence","volume":"59","author":"Liao","year":"2025","journal-title":"J Microbiol Immunol Infect"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2025.106093","article-title":"Cd163 impairs HBV clearance in mice by regulating intrahepatic T cell immune response via an IL-10-dependent mechanism","volume":"235","author":"Liu","year":"2025","journal-title":"Antiviral Res"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2025.1600686","article-title":"Tim4+macrophages suppress the proinflammatory response to maintain the chronic alveolar echinococcosis infection","volume":"15","author":"Wang","year":"2025","journal-title":"Front Cell Infect Microbiol"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004032","article-title":"Hepatitis B virus infection and immunopathogenesis in a humanized mouse model: induction of human-specific liver fibrosis and M2-like macrophages","volume":"10","author":"Bility","year":"2014","journal-title":"PloS Pathog"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2019.103909","article-title":"Newly excysted juveniles (NEJs) of Fasciola gigantica induce mice liver fibrosis and M2 macrophage-like phenotype in vivo","volume":"139","author":"Zhang","year":"2020","journal-title":"Microb Pathog"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmgh.2015.12.005","article-title":"Hepatitis C virus-induced monocyte differentiation into polarized M2 macrophages promotes stellate cell activation via TGF-beta","volume":"2","author":"Saha","year":"2016","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1038\/srep39520","article-title":"Chronic hepatitis C infection-induced liver fibrogenesis is associated with M2 macrophage activation","volume":"6","author":"Bility","year":"2016","journal-title":"Sci Rep"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202202033r","article-title":"Notch signaling inhibition after DAPT treatment exacerbates alveolar echinococcosis hepatic fibrosis by blocking M1 and enhancing M2 polarization","volume":"37","author":"Li","year":"2023","journal-title":"FASEB J"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.600635","article-title":"Dual role of hepatic macrophages in the establishment of the Echinococcus multilocularis metacestode in mice","volume":"11","author":"Wang","year":"2020","journal-title":"Front Immunol"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.980872","article-title":"Single-cell RNA sequencing to dissect the immunological network of liver fibrosis in Schistosoma japonicum-infected mice","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Immunol"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.570524","article-title":"The differential and dynamic progression of hepatic inflammation and immune responses during liver fibrosis induced by Schistosoma japonicum or carbon tetrachloride in mice","volume":"11","author":"Song","year":"2020","journal-title":"Front Immunol"},{"key":"B140","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1186\/s13071-022-05420-6","article-title":"Il-37 alleviates liver granuloma caused by Schistosoma japonicum infection by inducing alternative macrophage activation","volume":"15","author":"Ren","year":"2022","journal-title":"Parasit Vectors"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1295257","article-title":"Tumor-associated macrophages: an effective player of the tumor microenvironment","volume":"14","author":"Basak","year":"2023","journal-title":"Front Immunol"},{"key":"B142","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.21037\/atm-20-695","article-title":"Emerging neo adjuvants for harnessing therapeutic potential of M1 tumor associated macrophages (TAM) against solid tumors: Enusage of plasticity","volume":"8","author":"Nadella","year":"2020","journal-title":"Ann Transl Med"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2025.118180","article-title":"Glucosamine alleviates liver fibrosis through modulation of sinusoidal blood flow and hepatic immune responses","volume":"188","author":"Chen","year":"2025","journal-title":"BioMed Pharmacother"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1039\/d1fo03768d","article-title":"Chitooligosaccharides alleviate hepatic fibrosis by regulating the polarization of M1 and M2 macrophages","volume":"13","author":"Liu","year":"2022","journal-title":"Food Funct"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113834","article-title":"Si-Wu-Tang ameliorates bile duct ligation-induced liver fibrosis via modulating immune environment","volume":"155","author":"Ma","year":"2022","journal-title":"BioMed Pharmacother"},{"key":"B146","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.intimp.2017.10.019","article-title":"Inflammation is regulated by the adenosine derivative molecule, IFC-305, during reversion of cirrhosis in a CCl4 rat model","volume":"54","author":"P\u00e9rez-Cabeza de Vaca","year":"2018","journal-title":"Int Immunopharmacol"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1007\/s00011-022-01629-4","article-title":"Synergistic anti-inflammatory effect of gut microbiota and lithocholic acid on liver fibrosis","volume":"71","author":"Shao","year":"2022","journal-title":"Inflammation Res"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1038\/srep17192","article-title":"Astaxanthin prevents and reverses diet-induced insulin resistance and steatohepatitis in mice: a comparison with vitamin E","volume":"5","author":"Ni","year":"2015","journal-title":"Sci Rep"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1210\/en.2014-1776","article-title":"Prevention and reversal of lipotoxicity-induced hepatic insulin resistance and steatohepatitis in mice by an antioxidant carotenoid, beta-cryptoxanthin","volume":"156","author":"Ni","year":"2015","journal-title":"Endocrinology"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0098294","article-title":"Beta-cryptoxanthin alleviates diet-induced nonalcoholic steatohepatitis by suppressing inflammatory gene expression in mice","volume":"9","author":"Kobori","year":"2014","journal-title":"PloS One"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.20944\/preprints202310.0145.v1","article-title":"Omega-3 lipid mediators: Modulation of the M1\/M2 macrophage phenotype and its protective role in chronic liver diseases","volume":"24","author":"Videla","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00259.2020","article-title":"A dietary ketone ester mitigates histological outcomes of NAFLD and markers of fibrosis in high-fat diet fed mice","volume":"320","author":"Moore","year":"2021","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1016\/j.aanat.2020.151626","article-title":"Can dasatinib ameliorate the hepatic changes, induced by long term western diet, in mice","volume":"234","author":"Elsayed","year":"2021","journal-title":"Ann Anat"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.31083\/j.fbl2708242","article-title":"Antioxidants rich herbal formula Ger-Gen-Chyn-Lian-Tang protects lipotoxicity and ameliorates inflammation signaling through regulation of mitochondrial biogenesis and mitophagy in nonalcoholic fatty liver disease mice","volume":"27","author":"Wang","year":"2022","journal-title":"Front Biosci (Landmark Ed)"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.111598","article-title":"Wuling capsule modulates macrophage polarization by inhibiting the TLR4-NF-kappaB signaling pathway to relieve liver fibrosis","volume":"129","author":"Ren","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.155776","article-title":"Xiezhuo tiaozhi formula inhibits macrophage pyroptosis in the non-alcoholic fatty liver disease by targeting the SIRT1 pathway","volume":"131","author":"Tian","year":"2024","journal-title":"Phytomedicine"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e26129","article-title":"Chinese herbal decoction, Yi-Qi-Jian-Pi formula exerts anti-hepatic fibrosis effects in mouse models of CCl(4)-induced liver fibrosis","volume":"10","author":"Yang","year":"2024","journal-title":"Heliyon"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0038631","article-title":"Human amniotic epithelial cell transplantation induces markers of alternative macrophage activation and reduces established hepatic fibrosis","volume":"7","author":"Manuelpillai","year":"2012","journal-title":"PloS One"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2023.108563","article-title":"Therapeutic potential of stem cells in regeneration of liver in chronic liver diseases: Current perspectives and future challenges","volume":"253","author":"Yadav","year":"2024","journal-title":"Pharmacol Ther"},{"key":"B160","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13287-018-1122-8","article-title":"Transplantation of bone marrow mesenchymal stromal cells attenuates liver fibrosis in mice by regulating macrophage subtypes","volume":"10","author":"Luo","year":"2019","journal-title":"Stem Cell Res Ther"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1002\/bit.70047","article-title":"3D hESC exosome-derived circular RNA hsa_circ_0076798 inhibits M1 macrophage inflammatory response and alleviates liver fibrosis by suppressing TNF\/NF-kappaB pathway through miR-1184\/DICER1 axis","volume":"122","author":"Zhang","year":"2025","journal-title":"Biotechnol Bioeng"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.833878","article-title":"Mesenchymal stem cell-derived extracellular vesicles in liver immunity and therapy","volume":"13","author":"Wu","year":"2022","journal-title":"Front Immunol"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.14218\/jcth.2023.00381","article-title":"Role of exosomal modulation of macrophages in liver fibrosis","volume":"12","author":"Fan","year":"2024","journal-title":"J Clin Transl Hepatol"},{"key":"B164","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1186\/s13287-025-04370-x","article-title":"Uncovering the bequeathing potential of apoptotic mesenchymal stem cells via small extracellular vesicles for its enhanced immunomodulatory and regenerative ability","volume":"16","author":"Mendiratta","year":"2025","journal-title":"Stem Cell Res Ther"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2025.123295","article-title":"Modification of MSCs with aHSCs-targeting peptide pPB for enhanced therapeutic efficacy in liver fibrosis","volume":"321","author":"Yuan","year":"2025","journal-title":"Biomaterials"},{"key":"B166","doi-asserted-by":"publisher","first-page":"36","DOI":"10.7150\/thno.37301","article-title":"Liver-targeted delivery of TSG-6 by calcium phosphate nanoparticles for the management of liver fibrosis","volume":"10","author":"Wang","year":"2020","journal-title":"Theranostics"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.05.022","article-title":"Cytotherapy with M1-polarized macrophages ameliorates liver fibrosis by modulating immune microenvironment in mice","volume":"67","author":"Ma","year":"2017","journal-title":"J Hepatol"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109178","article-title":"Effect of different types of macrophages on hepatic fibrosis in Echinococcus granulosus mice","volume":"117","author":"Li","year":"2019","journal-title":"BioMed Pharmacother"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1177\/09636897211004090","article-title":"Infusion of Kupffer cells expanded in vitro ameliorated liver fibrosis in a murine model of liver injury","volume":"30","author":"Li","year":"2021","journal-title":"Cell Transplant"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1631\/jzus.b1700003","article-title":"Comparison of the characteristics of macrophages derived from murine spleen, peritoneal cavity, and bone marrow","volume":"18","author":"Zhao","year":"2017","journal-title":"J Zhejiang Univ-Sci B"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1126\/science.1175202","article-title":"Identification of splenic reservoir monocytes and their deployment to inflammatory sites","volume":"325","author":"Swirski","year":"2009","journal-title":"Science"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2017.11","article-title":"Liver macrophages in tissue homeostasis and disease","volume":"17","author":"Krenkel","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2016.03.009","article-title":"A reservoir of mature cavity macrophages that can rapidly invade visceral organs to affect tissue repair","volume":"165","author":"Wang","year":"2016","journal-title":"Cell"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.3390\/ijms221910604","article-title":"MERTK(+\/hi) M2c macrophages induced by baicalin alleviate non-alcoholic fatty liver disease","volume":"22","author":"Junior","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1142\/s0192415x18500957","article-title":"M2(C) polarization by baicalin enhances efferocytosis via upregulation of MERTK receptor","volume":"46","author":"Lai","year":"2018","journal-title":"Am J Chin Med"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2024.01.034","article-title":"Chimeric antigen receptor-modified macrophages ameliorate liver fibrosis in preclinical models","volume":"80","author":"Dai","year":"2024","journal-title":"J Hepatol"},{"key":"B177","doi-asserted-by":"publisher","first-page":"10518","DOI":"10.1038\/s41598-017-11303-z","article-title":"M2-like macrophages in the fibrotic liver protect mice against lethal insults through conferring apoptosis resistance to hepatocytes","volume":"7","author":"Bai","year":"2017","journal-title":"Sci Rep"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.1021\/acsami.4c15494","article-title":"Quercetin-loaded melanin nanoparticles decorated with collagenase mediates synergistic immunomodulation and restores extracellular matrix homeostasis in liver fibrosis","volume":"17","author":"Li","year":"2025","journal-title":"ACS Appl Mater Interfaces"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1002\/ar.25333","article-title":"Soybean polyenylphosphatidylcholine (PPC) is beneficial in liver and extrahepatic tissue injury: An update in experimental research","volume":"307","author":"Mak","year":"2024","journal-title":"Anat Rec (Hoboken)"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.1038\/s41374-019-0255-4","article-title":"Pirfenidone prevents and reverses hepatic insulin resistance and steatohepatitis by polarizing M2 macrophages","volume":"99","author":"Chen","year":"2019","journal-title":"Lab Invest"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13020486","article-title":"Notch1 siRNA and AMD3100 ameliorate metabolic dysfunction-associated steatotic liver disease","volume":"13","author":"Zhu","year":"2025","journal-title":"Biomedicines"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2025.142395","article-title":"FAM134B-mediated ER-phagy alleviates alcohol-related liver fibrosis by reducing endoplasmic reticulum stress","volume":"308","author":"Wang","year":"2025","journal-title":"Int J Biol Macromol"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.859723","article-title":"Paeoniflorin ameliorates skeletal muscle atrophy in chronic kidney disease via AMPK\/SIRT1\/PGC-1alpha-mediated oxidative stress and mitochondrial dysfunction","volume":"13","author":"Li","year":"2022","journal-title":"Front Pharmacol"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2021.115668","article-title":"Pharmacological postconditioning with sappanone A ameliorates myocardial ischemia reperfusion injury and mitochondrial dysfunction via AMPK-mediated mitochondrial quality control","volume":"427","author":"Shi","year":"2021","journal-title":"Toxicol Appl Pharmacol"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.1097\/hc9.0000000000000089","article-title":"miR-34a regulates macrophage-associated inflammation and angiogenesis in alcohol-induced liver injury","volume":"7","author":"Wan","year":"2023","journal-title":"Hepatol Commun"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2024.155942","article-title":"The mitochondrial TSPO ligand atriol mitigates metabolic-associated steatohepatitis by downregulating CXCL1","volume":"159","author":"Li","year":"2024","journal-title":"Metabolism"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.64898\/2025.12.18.694904","article-title":"Novel highly homeostatic B cells induced by immunomodulatory oligonucleotide IMT504","author":"Rodriguez","year":"2025","journal-title":"bioRxiv"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.1002\/iub.1518","article-title":"Curcumin inhibits aerobic glycolysis in hepatic stellate cells associated with activation of adenosine monophosphate-activated protein kinase","volume":"68","author":"Lian","year":"2016","journal-title":"IUBMB Life"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2022.05.004","article-title":"Inhibition of ATP-citrate lyase improves NASH, liver fibrosis, and dyslipidemia","volume":"34","author":"Morrow","year":"2022","journal-title":"Cell Metab"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.1016\/j.crphar.2021.100051","article-title":"ATP citrate lyase inhibitor bempedoic acid alleviate long term HFD induced NASH through improvement in glycemic control, reduction of hepatic triglycerides & total cholesterol, modulation of inflammatory & fibrotic genes and improvement in NAS score","volume":"2","author":"Sanjay","year":"2021","journal-title":"Curr Res Pharmacol Drug Discov"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101193","article-title":"Combination of an ACLY inhibitor with a GLP-1R agonist exerts additive benefits on nonalcoholic steatohepatitis and hepatic fibrosis in mice","volume":"4","author":"Desjardins","year":"2023","journal-title":"Cell Rep Med"},{"key":"B192","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41573-021-00367-2","article-title":"Lipogenesis inhibitors: Therapeutic opportunities and challenges","volume":"21","author":"Batchuluun","year":"2022","journal-title":"Nat Rev Drug Discov"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.1098\/rsob.240303","article-title":"GLP-1\/GLP-1R axis: From metabolism (obesity and T2DM) to immunity","volume":"15","author":"Kumar","year":"2025","journal-title":"Open Biol"},{"key":"B194","doi-asserted-by":"publisher","first-page":"6296","DOI":"10.1038\/s41467-020-20141-z","article-title":"Macrophage ATP citrate lyase deficiency stabilizes atherosclerotic plaques","volume":"11","author":"Baardman","year":"2020","journal-title":"Nat Commun"},{"key":"B195","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.immuni.2019.11.009","article-title":"Toll-like receptor signaling rewires macrophage metabolism and promotes histone acetylation via ATP-citrate lyase","volume":"51","author":"Lauterbach","year":"2019","journal-title":"Immunity"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.12.018","article-title":"Spatial proteogenomics reveals distinct and evolutionarily conserved hepatic macrophage niches","volume":"185","author":"Guilliams","year":"2022","journal-title":"Cell"},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2023.100877","article-title":"Steatosis drives monocyte-derived macrophage accumulation in human metabolic dysfunction-associated fatty liver disease","volume":"5","author":"Chan","year":"2023","journal-title":"JHEP Rep"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1631-3","article-title":"Resolving the fibrotic niche of human liver cirrhosis at single-cell level","volume":"575","author":"Ramachandran","year":"2019","journal-title":"Nature"},{"key":"B199","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0082163","article-title":"Hepatic crown-like structure: A unique histological feature in non-alcoholic steatohepatitis in mice and humans","volume":"8","author":"Itoh","year":"2013","journal-title":"PloS One"},{"key":"B200","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1097\/00005176-199408000-00010","article-title":"Effect of a medium dose of ursodeoxycholic acid with or without taurine supplementation on the nutritional status of patients with cystic fibrosis: A randomized, placebo-controlled, crossover trial","volume":"19","author":"Merli","year":"1994","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B201","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/s0168-8278(96)80327-8","article-title":"Ursodeoxycholic acid and prednisolone versus ursodeoxycholic acid and placebo in the treatment of early stages of primary biliary cirrhosis","volume":"25","author":"Leuschner","year":"1996","journal-title":"J Hepatol"},{"key":"B202","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa060326","article-title":"A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis","volume":"355","author":"Belfort","year":"2006","journal-title":"N Engl J Med"},{"key":"B203","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2008.06.047","article-title":"Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis","volume":"135","author":"Aithal","year":"2008","journal-title":"Gastroenterology"},{"key":"B204","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1111\/j.1365-2036.2011.04912.x","article-title":"Meta-analysis: pioglitazone improves liver histology and fibrosis in patients with non-alcoholic steatohepatitis","volume":"35","author":"Boettcher","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"B205","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24558","article-title":"Rosiglitazone versus rosiglitazone and metformin versus rosiglitazone and losartan in the treatment of nonalcoholic steatohepatitis in humans: a 12-month randomized, prospective, open- label trial","volume":"54","author":"Torres","year":"2011","journal-title":"Hepatology"},{"key":"B206","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctim.2007.08.004","article-title":"The effect of QuYuHuaTanTongLuo Decoction on the non-alcoholic steatohepatitis","volume":"16","author":"Zhang","year":"2008","journal-title":"Complement Ther Med"},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.1038\/s41430-018-0382-9","article-title":"The effects of curcumin supplementation on liver enzymes, lipid profile, glucose homeostasis, and hepatic steatosis and fibrosis in patients with non-alcoholic fatty liver disease","volume":"73","author":"Saadati","year":"2019","journal-title":"Eur J Clin Nutr"},{"key":"B208","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s12876-019-1055-4","article-title":"Curcumin and inflammation in non-alcoholic fatty liver disease: a randomized, placebo controlled clinical trial","volume":"19","author":"Saadati","year":"2019","journal-title":"BMC Gastroenterol"},{"key":"B209","doi-asserted-by":"publisher","DOI":"10.1097\/hep.0000000000000937","article-title":"Effect of phospholipid curcumin Meriva on liver histology and kidney disease in nonalcoholic steatohepatitis: A randomized, double-blind, placebo-controlled trial","volume":"81","author":"Musso","year":"2025","journal-title":"Hepatology"},{"key":"B210","doi-asserted-by":"publisher","DOI":"10.1097\/mcg.0b013e31815591aa","article-title":"Highly purified eicosapentaenoic acid treatment improves nonalcoholic steatohepatitis","volume":"42","author":"Tanaka","year":"2008","journal-title":"J Clin Gastroenterol"},{"key":"B211","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1053\/j.gastro.2014.04.046","article-title":"No significant effects of ethyl-eicosapentanoic acid on histologic features of nonalcoholic steatohepatitis in a phase 2 trial","volume":"147","author":"Sanyal","year":"2014","journal-title":"Gastroenterology"},{"key":"B212","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0168216","article-title":"Docosahexanoic acid plus vitamin D treatment improves features of NAFLD in children with serum vitamin D deficiency: results from a single centre trial","volume":"11","author":"Della Corte","year":"2016","journal-title":"PloS One"},{"key":"B213","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-03406-8","article-title":"Autologous macrophage therapy for liver cirrhosis: a phase 2 open-label randomized controlled trial","volume":"31","author":"Brennan","year":"2025","journal-title":"Nat Med"},{"key":"B214","doi-asserted-by":"publisher","DOI":"10.1089\/scd.2011.0074","article-title":"Potential therapeutic application of intravenous autologous bone marrow infusion in patients with alcoholic liver cirrhosis","volume":"20","author":"Saito","year":"2011","journal-title":"Stem Cells Dev"},{"key":"B215","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000000758","article-title":"A CONSORT-compliant, randomized, double-blind, placebo-controlled pilot trial of purified anthocyanin in patients with nonalcoholic fatty liver disease","volume":"94","author":"Zhang","year":"2015","journal-title":"Med (Baltimore)"},{"key":"B216","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1016\/j.cgh.2017.04.016","article-title":"A randomized trial of silymarin for the treatment of nonalcoholic steatohepatitis","volume":"15","author":"Wah Kheong","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B217","doi-asserted-by":"publisher","DOI":"10.3390\/md19030148","article-title":"Fucoidan and fucoxanthin attenuate hepatic steatosis and inflammation of NAFLD through modulation of leptin\/adiponectin axis","volume":"19","author":"Shih","year":"2021","journal-title":"Mar Drugs"},{"key":"B218","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29514","article-title":"The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: A randomized, phase 2 trial","volume":"67","author":"Loomba","year":"2018","journal-title":"Hepatology"},{"key":"B219","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29477","article-title":"A randomized, placebo-controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis","volume":"67","author":"Friedman","year":"2018","journal-title":"Hepatology"},{"key":"B220","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.cgh.2023.04.003","article-title":"Cenicriviroc lacked efficacy to treat liver fibrosis in nonalcoholic steatohepatitis: AURORA phase III randomized study","volume":"22","author":"Anstee","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B221","doi-asserted-by":"publisher","DOI":"10.14341\/dm13340","article-title":"Ipragliflozin improves the hepatic outcomes of patients with diabetes with NAFLD","volume":"6","author":"Takahashi","year":"2022","journal-title":"Hepatol Commun"},{"key":"B222","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.86232","article-title":"Efficacy of sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease: A systematic review of randomized controlled trials","volume":"17","author":"Ahmed","year":"2025","journal-title":"Cureus"},{"key":"B223","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcd.2024.03.005","article-title":"Effects of GLP-1 receptor agonists on the degree of liver fibrosis and CRP in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: A systematic review and meta-analysis","volume":"18","author":"Fang","year":"2024","journal-title":"Prim Care Diabetes"},{"key":"B224","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1056\/nejmoa2401943","article-title":"Tirzepatide for metabolic dysfunction-associated steatohepatitis with liver fibrosis","volume":"391","author":"Loomba","year":"2024","journal-title":"N Engl J Med"},{"key":"B225","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2413258","article-title":"Phase 3 trial of semaglutide in metabolic dysfunction-associated steatohepatitis","volume":"392","author":"Sanyal","year":"2025","journal-title":"N Engl J Med"},{"key":"B226","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.793203","article-title":"Efficacy of off-label therapy for non-alcoholic fatty liver disease in improving non-invasive and invasive biomarkers: A systematic review and network meta-analysis of randomized controlled trials","volume":"9","author":"Luo","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"B227","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1186\/s12876-023-02948-4","article-title":"Effect of Empagliflozin and Pioglitazone on left ventricular function in patients with type two diabetes and nonalcoholic fatty liver disease without established cardiovascular disease: a randomized single-blind clinical trial","volume":"23","author":"Attaran","year":"2023","journal-title":"BMC Gastroenterol"},{"key":"B228","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2023.102279","article-title":"Comparison between the effect of Empagliflozin and Pioglitazone added to metformin in patients with type 2 diabetes and nonalcoholic fatty liver disease","volume":"48","author":"Hooshmand Gharabagh","year":"2024","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"B229","doi-asserted-by":"publisher","DOI":"10.1111\/jebm.70021","article-title":"Efficacy of hypoglycemic agents in metabolic dysfunction associated steatotic liver disease (MASLD): A systematic review and network meta-analysis","volume":"18","author":"Ren","year":"2025","journal-title":"J Evid Based Med"},{"key":"B230","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-025-03899-3","article-title":"The correlation between novel antidiabetic agents utilization and hepatocellular carcinoma incidence in type 2 diabetes patients: a network meta-analysis","volume":"81","author":"Lin","year":"2025","journal-title":"Eur J Clin Pharmacol"},{"key":"B231","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1111\/dom.13907","article-title":"Exenatide and dapagliflozin combination improves markers of liver steatosis and fibrosis in patients with type 2 diabetes","volume":"22","author":"Gastaldelli","year":"2020","journal-title":"Diabetes Obes Metab"},{"key":"B232","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1210\/endrev\/bnac018","article-title":"Glucagon-like peptide-1 receptor-based therapeutics for metabolic liver disease","volume":"44","author":"Yabut","year":"2023","journal-title":"Endocr Rev"},{"key":"B233","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2022.03.005","article-title":"SGLT-2 inhibitors and GLP-1 receptor agonists in metabolic dysfunction-associated fatty liver disease","volume":"33","author":"Moon","year":"2022","journal-title":"Trends Endocrinol Metab"},{"key":"B234","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.17037","article-title":"Mechanism of semaglutide in MASLD treatment: where is the master key","volume":"40","author":"Ezhilarasan","year":"2025","journal-title":"J Gastroenterol Hepatol"},{"key":"B235","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.123130","article-title":"SGLT2 inhibition reprograms systemic metabolism via FGF21-dependent and -independent mechanisms","volume":"4","author":"Osataphan","year":"2019","journal-title":"JCI Insight"},{"key":"B236","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.104215","article-title":"Cardiorenal protection of SGLT2 inhibitors-Perspectives from metabolic reprogramming","volume":"83","author":"Gao","year":"2022","journal-title":"EBioMedicine"},{"key":"B237","doi-asserted-by":"publisher","DOI":"10.3390\/metabo15080536","article-title":"SGLT2 inhibitors: multifaceted therapeutic agents in cardiometabolic and renal diseases","volume":"15","author":"Checa-Ros","year":"2025","journal-title":"Metabolites"},{"key":"B238","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(78)90101-0","article-title":"Functional macrophage cell lines transformed by Abelson leukemia virus","volume":"15","author":"Raschke","year":"1978","journal-title":"Cell"},{"key":"B239","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.intimp.2014.08.002","article-title":"THP-1 cell line: an in vitro cell model for immune modulation approach","volume":"23","author":"Chanput","year":"2014","journal-title":"Int Immunopharmacol"},{"key":"B240","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrep.2022.101383","article-title":"Comparison of monocytic cell lines U937 and THP-1 as macrophage models for in vitro studies","volume":"32","author":"Nascimento","year":"2022","journal-title":"Biochem Biophys Rep"},{"key":"B241","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.803037","article-title":"Macrophage polarization and its role in liver disease","volume":"12","author":"Wang","year":"2021","journal-title":"Front Immunol"},{"key":"B242","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/6181432","article-title":"AICAR-induced AMPK activation inhibits the noncanonical NF-kappaB pathway to attenuate liver injury and fibrosis in BDL rats","volume":"2018","author":"Zhu","year":"2018","journal-title":"Can J Gastroenterol Hepatol"},{"key":"B243","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2200182","article-title":"FABP5 deficiency impaired macrophage inflammation by regulating AMPK\/NF-kappaB signaling pathway","volume":"209","author":"Hou","year":"2022","journal-title":"J Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1792423\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T04:29:29Z","timestamp":1778560169000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1792423\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,12]]},"references-count":243,"alternative-id":["10.3389\/fimmu.2026.1792423"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1792423","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,12]]},"article-number":"1792423"}}